Home on the range where the buffalo roam Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D.B. Cooper who wrote (10528)	3/17/2003 12:47:38 PM
From: D.B. Cooper	Read Replies (2) of 13815

re: watch DNA today. I love analyst's like this NEW YORK, March 17 (Reuters) - Lazard Freres on Monday said it cut its price target for shares of Genentech Inc. (DNA), the world's second-biggest biotechnology company, to $36 from $37 because of ``revised product expectations.'' ``There is a high probability that one or more of the regulatory or clinical events this year will be negative, which could create a buying opportunity for DNA shares,'' analyst Joel Sendek said in a research note. Shares of Genentech closed at $32.26 on the New York Stock Exchange on Friday. REUTERS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next